Evidence map›Paper›PMID 30019892›Full record

ArticleACS sensors2018

Sensitive Detection of Exosomal Proteins via a Compact Surface Plasmon Resonance Biosensor for Cancer Diagnosis.

Chang Liu, Xie Zeng, Zijian An, Yunchen Yang, Maxwell Eisenbaum, Xiaodong Gu, Josep M Jornet, Grace K Dy, Mary E Reid, Qiaoqiang Gan and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS sensors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 198 citations in OpenAlex.

  1. Correlation between exosomal PD-L1 and prognosis in patients with cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Extracellular vesicles decoying across host immunity.Journal of leukocyte biology · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Nanomedicine Innovations for Lung Cancer Diagnosis and Therapy.ACS applied materials & interfaces · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Chang Liu
Xie Zeng
Zijian An
Yunchen Yang
Maxwell Eisenbaum
Xiaodong GuDepartment of General Surgery , Huashan Hospital, Fudan University , Shanghai , 200040 China.
Josep M Jornet
Grace K DyDepartment of Medicine , Roswell Park Comprehensive Cancer Center , Buffalo , New York 14263 , United States.
Mary E ReidDepartment of Medicine , Roswell Park Comprehensive Cancer Center , Buffalo , New York 14263 , United States.
Qiaoqiang Gan
University at Buffalo, State University of New York · USRoswell Park Comprehensive Cancer Center · USFudan University · CN

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Noninvasive detection of circulating RNAs for lung cancer early detection and prognosisR33CA191245 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WU, YUN · 2015 to 2018
$1.3M
NCATS NIH HHS UL1 TR001412NCI NIH HHS R33 CA191245
6 · The paper itself

Abstract

Exosomes are small extracellular vesicles released by cells for cell-cell communication. They play important roles in cancer development, metastasis, and drug resistance. Exosomal proteins have been demonstrated by many studies as promising biomarkers for cancer screening, diagnosis, and monitoring. Among many detection techniques, surface plasmon resonance (SPR) is a highly sensitive, label-free, and real-time optical detection method. Commercial prism-based wavelength/angular-modulated SPR sensors afford high sensitivity and resolution, but their large footprint and high cost limit their adaptability for clinical settings. Recently, a nanoplasmonic exosome (nPLEX) assay was developed to detect exosomal proteins for ovarian cancer diagnosis. However, comparing with conventional SPR biosensors, the broad applications of nanoplasmonic biosensors are limited by the difficult and expensive fabrication of nanostructures. We have developed an intensity-modulated, compact SPR biosensor (25 cm × 10 cm × 25 cm) which uses a conventional SPR sensing mechanism and does not require nanostructure fabrication. Calibration from glycerol showed that the compact SPR biosensor offered sensitivity of 9.258 × 10

Indexed as

Surface Plasmon ResonanceAgedB7-H1 AntigenBiomarkers, TumorBiosensing TechniquesCarcinoma, Non-Small-Cell LungCell Line, TumorErbB ReceptorsExosomesFemaleHumansLung NeoplasmsMaleMiddle AgedProtein Array AnalysisSurface PropertiesB7-H1 AntigenBiomarkers, TumorCD274 protein, humanErbB Receptorsbiosensorcancerexosomein vitro diagnosticssurface plasmon resonance

Identifiers

PMID30019892
PMCPMC8628517
OpenAlexW2884198871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.